COMMUNIQUÉS West-GlobeNewswire

Sunesis Pharmaceuticals to Present at Upcoming Investor Conferences
14/03/2018
SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that the Company will present at two upcoming investor conferences. Willie Quinn, Chief [...]
Carrie Arran Resources Announces Proposed Private Placement With Insider Participation
14/03/2018
TORONTO, March 14, 2018 (GLOBE NEWSWIRE) -- Carrie Arran Resources Inc. (the “ Corporation ”) is pleased to announce a proposed non-brokered private placement (the “ Private Placement ”) of up to 600,000 common shares [...]
Invuity Announces Proposed Public Offering of Common Stock
14/03/2018
SAN FRANCISCO, March 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ) ("Invuity" or the "Company"), a leading medical technology company focused on minimal access surgery, today announced that it intends to [...]
Aduro Biotech to Present at the 28th Annual Oppenheimer Healthcare Conference
14/03/2018
BERKELEY, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 28th Annual [...]
Trevena to Present at the Oppenheimer & Company 28th Annual Healthcare Conference
14/03/2018
CHESTERBROOK, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Oppenheimer & Company 28th Annual Healthcare Conference on Wednesday, March 21, [...]
Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
14/03/2018
- New positive clinical and translational data for both lead agents - Strong balance sheet with 2017 year-end cash and equivalents of $144.2 Million - Conference call at 1:30 pm Pacific today SEATTLE and SOUTH SAN [...]
La Jolla Pharmaceutical Company Announces $100 Million Public Offering of Common Stock
14/03/2018
SAN DIEGO, March 14, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) (La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients [...]
Arbutus Announces Corporate Update and Year-End 2017 Financial Results
14/03/2018
ARB-1467 Phase II Combination Study Beginning in 1Q18 Two New Drug Candidates Planned to Enter Clinical Development in 2H18 Over $200M in Cash Available to Fund Development of HBV Assets Company to Host a Corporate [...]
Capricor Presents Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
14/03/2018
Planning to Initiate HOPE-2 Clinical Trial To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology [...]
Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call
14/03/2018
PARSIPPANY, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (the “Company”), a fully integrated commercial and bioinformatics company that provides clinically useful molecular [...]
EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018
14/03/2018
LYON, France, March 14, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the year ended December 31, 2017, after the close of [...]
Virbac : operating profit from ordinary activities 2017 comparable to 2016
14/03/2018
Virbac: operating profit from ordinary activities 2017 comparable to 2016 Public release dated March 14, 2018 CONSOLIDATED DATA AS OF DECEMBER 31 st in € million 2017 2016 % change 2017/2016 Revenue from ordinary [...]
Virbac : résultat opérationnel courant 2017 comparable à 2016
14/03/2018
Virbac: résultat opérationnel courant 2017 comparable à 2016 Communiqué diffusé le 14 mars 2018 CHIFFRES CONSOLIDÉS AU 31 DÉCEMBRE en millions € 2017 2016 Évolution 2017/2016 Chiffre d'affaires 861,9 871,8 -1,1% [...]
BriaCell Appoints Top Social Media Marketing Analyst
14/03/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Cognition Therapeutics Presenting Evidence for Elayta Synaptic Protection in Alzheimer’s Patients at Combined AAT-AD/PD Focus Meeting
14/03/2018
Pittsburgh, March 14, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and [...]
Tabula Rasa HealthCare to Participate in the Oppenheimer 28th Annual Healthcare Conference
14/03/2018
MOORESTOWN, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
14/03/2018
FIT Biotech Oy Company release March 14, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Amedisys to Present at the 28th Annual Oppenheimer Healthcare Conference
14/03/2018
BATON ROUGE, La., March 14, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive [...]
Zynerba Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference
14/03/2018
DEVON, Pa., March 14, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]

Pages